The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Greek Supreme Court To Rule On Legality Of Referendum

Fri, 03rd Jul 2015 10:15

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
The Royal Bank of Scotland Group could face a penalty of as much as USD13 billion depending on the outcome of a US mortgage securities lawsuit, Bloomberg News reported. According to the report the US Federal Housing Finance Agency, which is suing on behalf of Fannie Mae and Freddie Mac, estimated that amount in a court filing in a related case.
----------
Anglo-Dutch consumer goods giant Unilever said it has agreed to buy US skincare company Murad. Terms of the deal were not disclosed. Founded in 1989 in Los Angeles, Murad, which had a turnover of USD115 million in 2014, will be incorporated into Unilever's Prestige division. The Murad deal follows Unilever's recent acquisitions of Dermalogica, Kate Somerville and REN.
----------
Ofcom has fined mobile operator EE GBP1 million for failing to comply with rules on handling customer complaints, the UK media and communications regulator said. EE is currently in the process of being acquired by telecoms company BT Group. The Ofcom investigation found EE did not provide certain customers with accurate or adequate information about their right to take their complaint to an alternative dispute resolution during the period under review, which covered July 22, 2011 to April 8, 2014.
----------
GlaxoSmithKline's ViiV Healthcare signed a strategic manufacturing agreement with Desano Pharmaceuticals on Thursday for the manufacturing of dolutegravir, ViiV's HIV medicine. The agreement will offer an additional source of the dolutegravir active pharmaceutical ingredient and will allow ViiV to offer a competitive supply of the finished product, marketed under the name Tivicay, for China and a number of developing countries, subject to national approvals.
----------
Ferrexpo said pellet production rose in the second quarter and in the first half as the company continues to produce more high-quality pellets. The iron ore miner operating in Ukraine said total pellet production in the second quarter experienced a small lift to 2.9 million tonnes, bringing total first half production to 5.8 million tonnes, which is up 8.3% from 5.4 million tonnes a year earlier.
----------
MARKETS
----------
London shares are mostly lower mid-morning, trading in a narrow range with the US stock market closed and ahead of the Greek referendum on its bailout provisions on Sunday.
----------
FTSE 100: down 0.3% at 6,610.30
FTSE 250: down 0.4% at 17,625.08
AIM ALL-SHARE: up 0.5% at 765.41
----------
The pound was higher against the dollar after UK Markit services Purchasing Manager's Index, the day's only domestic economic data, came in ahead of expectations.
----------
GBP: up at USD1.5632
EUR: up at USD1.1113

GOLD: up at USD1168.20 per ounce
OIL (Brent): down at USD61.69 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
Greek officials were braced for a decision by the country's supreme administrative court on the legality of the bailout referendum ahead of rival campaign rallies in central Athens. According to the Council of Europe, a democracy watchdog, Sunday's referendum will not meet international standards, as voters have not been given enough time to prepare and the question posed is too vague. But Triantafyllia Lina Papadopoulou, a professor of constitutional law at the Aristotle University of Thessaloniki, says the referendum is unlikely to be challenged. "Even if they go into the substance, I think it will be too late to annul the referendum," she told dpa.
----------
Greece requires at least EUR36 billion from Eurozone over the coming three years on concessional terms to maintain its finances sustainable, the International Monetary Fund said in a report. In a preliminary draft of its Greek debt sustainability analysis, the IMF said the funding requirement is projected to reach around EUR50 billion from October 2015 to end 2018, requiring at least EUR36 billion from European creditors on highly concessional terms.
----------
The UK service sector logged strong growth in June following a temporary lull in May linked to the recent election. The headline Markit/Chartered Institute of Procurement & Supply Purchasing Managers' Index rose to 58.5 in June from a five-month low of 56.5 in May. It was forecast to rise to 57.5. Data suggests that the second quarter of 2015 was the strongest on average since the third quarter of 2014.
----------
Ireland's service sector expanded at the fastest pace in almost nine years in June, driven by continued gains from improvements in economic conditions, survey figures from Markit Economics and Investec showed. The Investec services Purchasing Managers' Index rose to 63.3 in June from 61.4 in the previous month. A reading above 50 indicates expansion in the sector. The services activity increased at the strongest pace since September 2006.
----------
China's securities market regulator said that it has opened an investigation into suspected market manipulation. The China Securities Regulatory Commission said it has set up a team to look for "clues of illegal manipulation across markets" and irregularities between securities and futures trading."Those suspected of a crime will be resolutely transferred to the police for investigation," spokesman Zhang Xiaojun said in comments on the regulator's official microblog Thursday.
----------
The services sector in China continued to expand in June, but at a slower pace, the latest PMI from HSBC Bank showed, with a PMI score of 51.8. That's down from 53.5 in May, although it remains above the line of 50 that separates expansion from contraction. The composite index came in at 50.6, down from 51.2 in the previous month and touching a 13-month low.
----------
Iran sent mixed messages on whether it is ready to accept intrusive nuclear inspections foreseen in a deal with six world powers, following a visit by International Atomic Energy Agency chief Yukiya Amano in Tehran. Amano was expected to report back Friday in Vienna to the group of six, which are negotiating with Iran on scaling back the Islamic republic's nuclear programme and allow deep scrutiny by IAEA inspectors, in return for sanctions relief.
----------
An airstrike has killed a leading Islamic State fighter in Syria, the Pentagon said. Tunisian militant Tarik bin Tahar al-Awni al-Harzi was killed in Syria near the border with Iraq on June 16. His death would make it harder for Islamic State to move weapons and fighters in and out of Iraq and Syria, Pentagon spokesman Jeff Davis said in a statement.
----------
Syrian opposition rebels launched a large-scale attack on regime strongholds in the northern province of Aleppo, killing and wounding some 80 people, a monitoring group said. "This is the heaviest attack by rebel forces Aleppo has witnessed since two years, as more than 400 shells fell on regime-held areas in Aleppo," Rami Abdel Rahman, head of the Syrian Observatory for Human Rights, told dpa.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.